Lehrstuhl für Innere Medizin I (Medizin 1)

Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis (2018) Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T Conference contribution Recording and Optimizing the Nutritional Behavior of oncological Patients by using a Smartphone App (OncoFood) (2018) Orlemann T, Zenker B, Reljic D, Meyer J, Oberlaender J, Herrmann HJ, Eskofier B, et al. Conference contribution Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study (2018) Tontini GE, Mudter J, Günther C, Milani V, Atreya R, Rath T, Nagel A, et al. Journal article Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018) Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al. Conference contribution Modern Endoscopic Imaging in Diagnosis and Surveillance of Inflammatory Bowel Disease Patients (2018) Hundorfean G, Pereira SP, Karstensen JG, Vilmann P, Saftoiu A Journal article Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study (2018) Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, et al. Conference contribution Relationship between Metabolic Toxicity and Efficacy of Everolimus in Patients with Neuroendocrine Tumors (NETs): A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials (2018) Fazio N, Carnaghi C, Buzzoni R, Valle J, Herbst F, Ridolfi A, Strosberg J, et al. Conference contribution Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts (2018) Schellhaas B, Strobel D, Stumpf M, Ganslmayer M, Pfeifer L, Görtz R, Neurath M, Zopf S Journal article Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article